Opko Health Inc (NASDAQ:OPK) shares traded 0.83% up during most recent session to reach at the closing price of $3.65. The stock exchanged hands 3.14 Million shares versus average trading capacity of 4.93 Million shares, yielding a market cap of $1.9 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $10 within the next 52-weeks. The mean target projections are based on 3 opinions.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have Opko Health Inc (NASDAQ:OPK) high price target of $19 and with a conservative view have low price target of $4.
JP Morgan “Downgrades” Opko Health Inc (NASDAQ:OPK) in a research note issued to investors on 3/02/18 to Underweight.
Additionally on 9/14/17 JP Morgan “Downgrades” Opko Health Inc (NASDAQ:OPK) to Neutral setting price target at $7 and on 8/18/17 Cantor Fitzgerald “Initiates Coverage On” the stock to Overweight at $20. Furthermore on 3/14/17 Guggenheim “Initiates Coverage On” the stock to Buy at $25.
On the other hand the company has Relative Strength Index (RSI 14) of 59.02 along with Average True Range (ATR 14) of 0.27, Consequently Opko Health Inc (NASDAQ:OPK)’s weekly and monthly volatility is 6.65%, 8.69% respectively. The company’s beta value is at 1.91.
In terms of Buy, Sell or Hold recommendations, Opko Health Inc (NASDAQ:OPK) has analysts’ mean recommendation of 2.5. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
According to analysts Opko Health Inc (NASDAQ:OPK)’s minimum EPS for the current quarter is at $-0.1 and can go high up to $-0.07. The consensus mean EPS for the current quarter is at $-0.09 derived from a total of 3 estimates from the analysts who have weighed in on projected earnings. However the company reported $-0.32 earnings per share for the same quarter during last year.
Previously Opko Health Inc (NASDAQ:OPK) reported $-0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $-0.08 by $0.03. The company posted an earnings surprise of 37.5%.
Opko Health Inc (NASDAQ:OPK)’s revenue estimates for the current quarter are $245.27 Million according to 3 number of analysts, for the current quarter the company has high revenue estimates of $251.7 Million in contradiction of low revenue estimates of $239.1 Million. For the current year the company’s revenue estimates are $1.01 Billion compared to low analyst estimates of $1.01 Billion and high estimates of $1.02 Billion according to 3 number of analysts.
Currently Opko Health Inc (NASDAQ:OPK)’s shares owned by insiders are 5.1%, whereas shares owned by institutional owners are 27.5%. However the six-month change in the insider ownership was recorded 3.06%, as well as three-month change in the institutional ownership was recorded 0.13%.
Opko Health Inc (NASDAQ:OPK)’s trailing twelve month revenues are $962.1 Million, whereas its price to sales ratio for the same period is 1.97. Its book value per share for the most recent quarter is $3.2 while its price to book ratio for the same period is 1.14, as for as the company’s cash per share for the most recent quarter is $0.08, however its price to cash per share ratio for the same period is 43.46. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.